Our Mission

To become a world leader in the development of targeted therapies for NASH and viral diseases to address important unmet medical needs.
Learn More

Pipeline

Drawing upon our extensive experience in developing therapeutics for chronic liver diseases and viral infections, we are building a pipeline of potentially best-in-class drug candidates. These drug candidates target multiple clinically validated mechanisms of action and are designed to become transformative treatment options NASH and viral diseases.
Learn More

Management Team

Our management team brings together years of experience and expertise with the goal of making Aligos a world leader in developing targeted therapies for hepatologic diseases and viral infections that affect millions of people around the world.

Learn More

Our Mission

To become a world leader in the development of targeted therapies for NASH and viral diseases to address important unmet medical needs.
Learn More

Meet the Aligos TeamAligos has brought together a group of remarkable individuals with years of experience and expertise.

Learn More

Meet the Aligos Team

Aligos has brought together a group of remarkable individuals with years of experience and expertise.

Learn More

Scientific Overview

We are engaged in the discovery and development of purpose-built, potentially best-in-class small molecule and oligonucleotide drug candidates that target clinically validated mechanisms of action in NASH and viral diseases
Learn More